• editor@ijmra.in
  • ISSN[Online] : 2643-9875  ||  ISSN[Print] : 2643-9840

Volume 07 Issue 01 January 2024

The Cardioprotective Effect of Nacetylcysteine on Doxorubicin Induced Cardiotoxicity in Heart Tissue of Rats.
1Suat Çakına, 2Latife Ceyda İrkin, 3Şamil Öztürk
1Çanakkale Onsekiz Mart University, Health Service Vocational College, Çanakkale-Turkey
2Çanakkale Onsekiz Mart University, Canakkale Faculty of Applied Sciences, Department of Fisheries Technology, Çanakkale-Turkey
3Çanakkale Onsekiz Mart University, Health Service Vocational College, Çanakkale-Turkey
DOI : https://doi.org/10.47191/ijmra/v7-i01-23

Google Scholar Download Pdf
ABSTRACT:

Doxorubicin (DOX) is a chemotherapeutic agent and is widely used in cancer treatment. There are some studies suggesting oxidative stress-induced toxic changes in the liver due to DOX administration. The aim of this study was to reveal the oxidative damage of DOX in liver tissue at molecular level and to evaluate the protective effect of N-acetylcysteine (NAC) against DOX oxidative damage. Twenty four rats weighing 150-200 g were randomly divided into four equal groups; group I : control, group 2: received a single dose of DOX, group 3: received NAC for 28 days and group 4: received a single dose of DOX, followed by NAC for 28 days. At the end of the experiment, heart tissues were taken from all animals. Malondialdehyde (MDA), Total Antioxidant Capacity (TAC), Total Oxidant Capacity (TOC) levels were determined in these samples by spectrophotometric methods. It was determined that TOC level increased, TAC levels decreased in the group given DOX compared to the control group. In addition, TAC levels increased in the DOX+NAC group (p0.05). It was concluded that DOX administration increased oxidative stress and NAC administration could prevent it. NAC caused modulatory effects on oxidative stress and antioxidant redox system in DOX-induced heart toxicity in the rat.

KEYWORDS:

Doxorubicin, N-Acetylcysteine, Heart, Oxidative stress.

REFERENCES
1) Arica, V., Demir İ, H., Tutanc, M., Basarslan, F., Arica, S., Karcoıglu, M., Nacar, A. (2013). N-acetylcysteine prevents doxorubucine-induced cardiotoxicity in rats. Hum Exp Toxicol, 32(6), 655-661. doi:10.1177/0960327112467043.

2) Boucher, F., Coudray, C., Tirard, V., Barandier, C., Tresallet, N., Favier, A., & de Leiris, J. (1995). Oral selenium supplementation in rats reduces cardiac toxicity of adriamycin during ischemia and reperfusion. Nutrition, 11(5 Suppl), 708-711.

3) Cassidy, S. C., Chan, D. P., Rowland, D. G., & Allen, H. D. (1998). Effects of doxorubicin on diastolic function, contractile reserve, and ventricular-vascular coupling in piglets. Pediatr Cardiol, 19(6), 450-457. doi:10.1007/s002469900355.

4) Elsherbiny, N. M., Salama, M. F., Said, E., El-Sherbiny, M., & Al-Gayyar, M. M. H. (2016). Crocin protects against doxorubicin-induced myocardial toxicity in rats through down-regulation of inflammatory and apoptic pathways. Chemico-Biological Interactions, 247, 39-48. doi:https://doi.org/10.1016/j.cbi.2016.01.014.

5) Fadillioğlu, E., Erdoğan, H., Söğüt, S., & Kuku, I. (2003). Protective effects of erdosteine against doxorubicin-induced cardiomyopathy in rats. J Appl Toxicol, 23(1), 71-74. doi:10.1002/jat.889.

6) Hajra, S., Basu, A., Singha Roy, S., Patra, A. R., & Bhattacharya, S. (2017). Attenuation of doxorubicin-induced cardiotoxicity and genotoxicity by an indole-based natural compound 3,3'-diindolylmethane (DIM) through activation of Nrf2/ARE signaling pathways and inhibiting apoptosis. Free Radic Res, 51(9-10), 812-827. doi:10.1080/10715762.2017.1381694.

7) Hrelia, S., Fiorentini, D., Maraldi, T., Angeloni, C., Bordoni, A., Biagi, P. L., & Hakim, G. (2002). Doxorubicin induces early lipid peroxidation associated with changes in glucose transport in cultured cardiomyocytes. Biochim Biophys Acta, 1567(1-2), 150-156. doi:10.1016/s0005-2736(02)00612-0.

8) Kaya, H., Koc, A., Sogut, S., Duru, M., Yilmaz, H. R., Uz, E., & Durgut, R. (2008). The protective effect of N-acetylcysteine against cyclosporine A-induced hepatotoxicity in rats. J Appl Toxicol, 28(1), 15-20. doi:10.1002/jat.1245.

9) Lamas, D., Nicoud, M. B., Sterle, H. A., Carabajal, E., Tesan, F., Perazzo, J. C., Medina, V. A. (2015). Selective cytoprotective effect of histamine on doxorubicin-induced hepatic and cardiac toxicity in animal models. Cell Death Discovery, 1(1), 15059. doi:10.1038/cddiscovery.2015.59.

10) Mansour, H. H., El kiki, S. M., & Hasan, H. F. (2015). Protective effect of N-acetylcysteine on cyclophosphamide-induced cardiotoxicity in rats. Environmental Toxicology and Pharmacology, 40(2), 417-422. doi:https://doi.org/10.1016 /j.etap.2015. 07. 013.

11) Migrino, R. Q., Aggarwal, D., Konorev, E., Brahmbhatt, T., Bright, M., & Kalyanaraman, B. (2008). Early detection of doxorubicin cardiomyopathy using two-dimensional strain echocardiography. Ultrasound Med Biol, 34(2), 208-214. doi:10. 1016/j.ultrasmedbio.2007.07.018.

12) Ohkawa, H., Ohishi, N., & Yagi, K. (1979). Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical Biochemistry, 95(2), 351-358. doi:https://doi.org/10.1016/0003-2697(79)90738-3.

13) Olson, R. D., & Mushlin, P. S. (1990). Doxorubicin cardiotoxicity: analysis of prevailing hypotheses. Faseb j, 4(13), 3076-3086.

14) Polegato, B. F., Minicucci, M. F., Azevedo, P. S., Carvalho, R. F., Chiuso-Minicucci, F., Pereira, E. J., Matsubara, L. S. (2015). Acute Doxorubicin-Induced Cardiotoxicity is Associated with Matrix Metalloproteinase-2 Alterations in Rats. Cellular Physiology and Biochemistry, 35(5), 1924-1933. doi:10.1159/000374001.

15) Sathish, P., Paramasivan, V., Palani, V., & Sivanesan, K. (2011). N-acetylcysteine attenuates dimethylnitrosamine induced oxidative stress in rats. European Journal of Pharmacology, 654(2), 181-186. doi:https://doi.org/10.1016/j.ejphar.2010.10.080.

16) Sehirli, A. O., Sener, G., Satiroglu, H., & Ayanoğlu-Dülger, G. (2003). Protective effect of N-acetylcysteine on renal ischemia/reperfusion injury in the rat. J Nephrol, 16(1), 75-80.

17) Shahira, M. E., Menna El, G., Abeer, M. E. S., Omar, M. S., Zeinab, Y. A., Susanne, H., Thomas, S. (2016). The Cardenolide Glycoside Acovenoside A Affords Protective Activity in Doxorubicin-Induced Cardiotoxicity in Mice. Journal of Pharmacology and Experimental Therapeutics, 358(2), 262. doi:10.1124/jpet.116.232652.

18) Singh, P., Sharma, R., McElhanon, K., Allen, C. D., Megyesi, J. K., Beneš, H., & Singh, S. P. (2015). Sulforaphane protects the heart from doxorubicin-induced toxicity. Free Radical Biology and Medicine, 86, 90-101. doi:https://doi.org /10.1016/ j.freeradbiomed.2015.05.028.

19) Wahab, M. H., Akoul, E. S., & Abdel-Aziz, A. A. (2000). Modulatory effects of melatonin and vitamin E on doxorubicin-induced cardiotoxicity in Ehrlich ascites carcinoma-bearing mice. Tumori, 86(2), 157-162. doi:10.1177/030089160008600210.

20) Wang, F., Liu, S., Shen, Y., Zhuang, R., Xi, J., Fang, H., Cai, Z. (2014). Protective effects of N‑acetylcysteine on cisplatin‑induced oxidative stress and DNA damage in HepG2 cells. Exp Ther Med, 8(6), 1939-1945. doi:10.3892/etm.2014.2019.

21) Woźniak, G., & Anuszewska, E. L. (2002). Influence of vitamins C and E on cytotoxic activity of adriamycin in chosen cell cultures. Acta Pol Pharm, 59(1), 31-35.
Volume 07 Issue 01 January 2024

There is an Open Access article, distributed under the term of the Creative Commons Attribution – Non Commercial 4.0 International (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/), which permits remixing, adapting and building upon the work for non-commercial use, provided the original work is properly cited.


Our Services and Policies

Authors should prepare their manuscripts according to the instructions given in the authors' guidelines. Manuscripts which do not conform to the format and style of the Journal may be returned to the authors for revision or rejected.

The Journal reserves the right to make any further formal changes and language corrections necessary in a manuscript accepted for publication so that it conforms to the formatting requirements of the Journal.

International Journal of Multidisciplinary Research and Analysis will publish 12 monthly online issues per year,IJMRA publishes articles as soon as the final copy-edited version is approved. IJMRA publishes articles and review papers of all subjects area.

Open access is a mechanism by which research outputs are distributed online, Hybrid open access journals, contain a mixture of open access articles and closed access articles.

International Journal of Multidisciplinary Research and Analysis initiate a call for research paper for Volume 07 Issue 05 (May 2024).

PUBLICATION DATES:
1) Last Date of Submission : 26 May 2024 .
2) Article published within a week.
3) Submit Article : editor@ijmra.in or Online

Why with us

International Journal of Multidisciplinary Research and Analysis is better then other journals because:-
1 : IJMRA only accepts original and high quality research and technical papers.
2 : Paper will publish immediately in current issue after registration.
3 : Authors can download their full papers at any time with digital certificate.

The Editors reserve the right to reject papers without sending them out for review.

Authors should prepare their manuscripts according to the instructions given in the authors' guidelines. Manuscripts which do not conform to the format and style of the Journal may be returned to the authors for revision or rejected. The Journal reserves the right to make any further formal changes and language corrections necessary in a manuscript accepted for publication so that it conforms to the formatting requirements of the Journal.

Indexed In
Avatar Avatar Avatar Avatar Avatar Avatar Avatar Avatar Avatar Avatar Avatar Avatar Avatar Avatar Avatar Avatar Avatar Avatar Avatar Avatar Avatar Avatar Avatar Avatar Avatar Avatar Avatar Avatar Avatar Avatar Avatar Avatar Avatar Avatar Avatar Avatar